Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors

Radiation(2025)10.3390/radiation5040039Source: DataRank Database

Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors is a research paper published in Radiation (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (17)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Jen Zaborek ORCID,Ohyun Kwon ORCID,Adedamola O. Adeniyi,Caroline P. Kerr ORCID,Hansel Comas Rojas ORCID

Live enrichment

PubMed:42022812 OpenAlex:https://openalex.org/W4417160546

NIH National Cancer Institute

Grant: P01CA250972

CCC

Grant: NCI P30 CA014520

SAIRF MiLabs microSPECT/CT SIG

Grant: NIH S10OD028670-01

National Institutes of Biomedical Imaging and Bioengineering of the National Institutes of Health

Grant: R56EB029259

NCI NIH HHS

Grant: P30 CA014520

NIH HHS

Grant: S10 OD028670

FWCI

0.00

Citation Percentile

0.4%

goldLicense: cc-by

journalhttps://www.mdpi.com/2673-592X/5/4/39/pdf

publisherhttps://www.mdpi.com/2673-592X/5/4/39/pdf

journalhttps://doi.org/10.3390/radiation5040039

repositoryhttps://pubmed.ncbi.nlm.nih.gov/42022812

repositoryhttps://doaj.org/article/37608c454ec74167a7d6e1ddc21317cf

Fields of Study

Radiopharmaceutical Chemistry and ApplicationsNanoplatforms for cancer theranosticsCancer Immunotherapy and Biomarkers

Keywords

Immune systemIn vivoImmunotherapyEx vivoTherapeutic indexRadionuclide therapyMonoclonal antibodyStimulationGD2-targeted therapycombination immunoradiotherapydinutuximabdosimetryimmune checkpoint inhibitors (ICI)radiopharmaceutical therapy (RPT)